Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
5 Dow Stocks Outperforming the S&P 500 Year to Date
05:29pm, Thursday, 16'th Jun 2022
As investors continue monitoring the Federal Reserve's actions to control inflation, five Dow Jones Industrial Average stocks that have outperformed the Standard & Poor's 500 Index in the year to date
The Dow Got Crushed -- Here Are 4 Stocks That Survived the Bloodbath
05:22pm, Thursday, 16'th Jun 2022
The Dow Jones Industrial Average fell more than 740 points today.
7 Retirement Stocks to Buy for a Bear Market
06:15am, Thursday, 16'th Jun 2022
Investors looking for robust shares may consider these seven retirement stocks to buy for a bear market The post 7 Retirement Stocks to Buy for a Bear Market appeared first on InvestorPlace. More From
Merck (MRK) Gains But Lags Market: What You Should Know
09:45pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
Merck (MRK) closed the most recent trading day at $84.63, moving +0.15% from the previous trading session.
Pfizer (PFE) COVID Pill Ineffective in Standard Risk Patients
07:22pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
Pfizer (PFE) stops enrolling patients in a phase II/III study evaluating its COVID pill in standard-risk population after new data from this study showed that it is not all statistically significant.
7 Seriously Undervalued Dow Stocks to Buy Before Wall Street Catches On
06:46am, Wednesday, 15'th Jun 2022
Undervalued Dow stocks can be difficult to find, but this article is looking at seven that investors should consider buying right now. The post 7 Seriously Undervalued Dow Stocks to Buy Before Wall St
Merck (MRK) Keytruda Adjuvant Lung Cancer sBLA Accepted by FDA
02:33pm, Tuesday, 14'th Jun 2022 Zacks Investment Research
The FDA is expected to give its decision on Merck's (MRK) Keytruda sBLA for adjuvant stage IB-IIIA NSCLC, following complete surgical resection, on Jan 29, 2023.
Merck (MRK) Keytruda Adjuvant Lung Cancer sBLA Accepted by FDA
11:36am, Tuesday, 14'th Jun 2022
The FDA is expected to give its decision on Merck's (MRK) Keytruda sBLA for adjuvant stage IB-IIIA NSCLC, following complete surgical resection, on Jan 29, 2023.
Is There A Better Pick Over Merck Stock In Animal Health Space?
10:00am, Tuesday, 14'th Jun 2022
There is more to the comparison, and in the sections below, we discuss why we believe that ZTS stock will offer better returns than MRK stock in the next three years.
5 Warren Buffett Dividend Stocks That Should Dodge Runaway Inflation
07:35am, Tuesday, 14'th Jun 2022
If any investor has stood the test of time, it is Warren Buffett. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world.
Why the Dow Jones Industrial Average Has Avoided the Bear So Far
10:51pm, Monday, 13'th Jun 2022 The Motley Fool
On the day when the S&P 500 fell 20% from its highs, the Dow remained the relative outperformer.
Merck & Co., Inc. (MRK) CEO Rob Davis Presents at the Goldman Sachs 43rd Annual Global Healthcare Conference (Transcript)
08:45pm, Monday, 13'th Jun 2022
Merck & Co., Inc. (NYSE:MRK ) Goldman Sachs 43rd Annual Global Healthcare Conference June 13, 2022 6:20 PM ET Company Participants Rob Davis - President & Chief Executive Officer Dean Li - Executive V
Potential Merck Targets Now a Lot Cheaper
03:19pm, Monday, 13'th Jun 2022
While the stock market continues to be pummeled, one Dow Jones company seems to be holding its own. In the past month, shares of pharma giant Merck & Co. Inc. ( MRK , Financial) have been flat while t
Bristol Myers (BMY) Up 20.4% YTD: Will the Momentum Continue?
01:52pm, Monday, 13'th Jun 2022 Zacks Investment Research
Bristol Myers (BMY) has put up an impressive performance so far in 2022, and the momentum should continue.
2 Best Biotech Stocks to Buy Right Now
02:53pm, Saturday, 11'th Jun 2022 The Motley Fool
These two pharma stocks boast 3%-plus dividend yields, double the S&P 500 index's 1.5% dividend yield.
